Artificial intelligence and machine learning in drug discovery and development

• Published in: Intelligent medicine Vol. 2; no. 3; pp. 134 - 140
• Main Authors: Patel, Veer, Shah, Manan
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.08.2022; Elsevier
• Subjects: Artificial intelligence; Drug discovery; Machine learning; Artificial intelligence; Machine learning; Drug discovery
• ISSN: 2667-1026; 2667-1026
• DOI: 10.1016/j.imed.2021.10.001

The current rise of artificial intelligence and machine learning has been significant. It has reduced the human workload improved quality of life significantly. This article describes the use of artificial intelligence and machine learning to augment drug discovery and development to make them more efficient and accurate. In this study, a systematic evaluation of studies was carried out; these were selected based on prior knowledge of the authors and a keyword search in publicly available databases which were filtered based on related context, abstract, methodology, and full text. This body of work supported the roles of machine learning and artificial intelligence in facilitating drug development and discovery processes, making them more cost-effective or altogether eliminating the need for clinical trials, owing to the ability to conduct simulations using these technologies. They also enabled researchers to study different molecules more extensively, without any trials. The results of this paper demonstrate the prevalent application of machine learning and artificial intelligence methods in drug discovery, and indicate a promising future for these technologies; these results should enable researchers, students, and pharmaceutical industry to dive deeper into machine learning and artificial intelligence in a drug discovery and development context.